Munich Re Specialty broadens its offerings with life science liability insurance.

Munich Re Specialty–North America (MRS-NA) has launched a new business line focused on life science liability insurance, which aims to strengthen its presence in the growing healthcare and biotechnology sectors. This announcement was made on June 13, 2025, and reflects the rising demand for specialized coverage among companies in the life sciences field. The new … Read more

Blended coverage is on the rise, but so are the associated risks.

Professional liability insurance is becoming more complicated, with the lines between different types of coverage starting to blur. This shift presents both opportunities and challenges for businesses. Jacqueline A. Waters, a managing director at Aon, highlights that the traditional way of thinking about insurance coverage is outdated. Waters points out that in smaller and mid-sized … Read more

How cyber insurance providers are adjusting to the evolving ransomware landscape

Ransomware attacks are becoming more common and sophisticated, but the response from the insurance industry is changing. As of June 2025, experts are noticing that while the number of cyber incidents is rising, fewer companies are actually paying ransoms. This trend indicates that businesses are improving their cybersecurity practices and resilience. Insurance providers are evolving … Read more

According to WTW, innovation begins with a robust culture and effective leadership.

A new report from WTW, a global advisory firm, highlights the importance of leadership and culture in driving innovation within organizations. The analysis shows that as the insurance industry faces new risks and changing client needs, innovation must be a strategic priority, not just a spontaneous effort. The report reveals that many organizations struggle with … Read more

Could drug warranties transform the landscape of pharmaceutical risk management?

As the biotech industry pushes to create groundbreaking therapies, a new financial tool is gaining attention: drug warranties. These warranties aim to help pharmaceutical companies manage the risks associated with high-cost treatments that may not always deliver the expected results. In 2023, global insurance firm Marsh partnered with Octaviant Financial to introduce a specialized drug … Read more

US hospitals are bracing for challenges as the July 1 renewals approach, according to RPS.

As the July 1 renewal season approaches, U.S. hospitals are facing a challenging period in securing liability insurance. Experts warn that this year could bring one of the toughest cycles in recent memory, with significant changes expected in coverage options and costs. James McNitt, the healthcare practice leader at RPS, highlighted that hospitals will experience … Read more

Tariffs are prompting multinationals to reorganize their supply chains, which introduces new risks.

As global trade tensions continue to rise, multinational companies are taking steps to adapt. Many are diversifying their supply chains by nearshoring and friend-shoring. These strategies aim to reduce reliance on specific regions and enhance resilience amid uncertain tariff policies. Nearshoring involves moving production closer to a company’s main market. For example, a U.S. company … Read more

The insurance industry faces challenges in managing the expenses associated with ELD mandates and rising verdict amounts.

As electronic logging devices (ELDs) become a permanent requirement for trucking companies, many fleet operators and insurers are facing new challenges. Smaller carriers are feeling the pressure the most, as they struggle with the costs associated with compliance. The ELD mandate was designed to help drivers follow hours-of-service regulations. However, it requires fleets to install … Read more

Mergers and acquisitions gain momentum with developments in AI, insurance, and private equity.

Global mergers and acquisitions (M&A) are expected to slow down in 2025 due to rising geopolitical tensions and economic worries. A survey by Norton Rose Fulbright, conducted in early 2025, gathered insights from 200 senior executives involved in cross-border deals worth over $200 million. Initially, more than half of the executives surveyed anticipated an increase … Read more